News

Investigators evaluated patients from 3 Chicago hospital systems and assessed risk factors associated with thrombosis.

Early assessment from an Australian team of investigators is targeting a pathway linked to hemoglobin expression.

High levels of fetal hemoglobin have previously been linked to the mitigation of morbidity and mortality of sickle cell anemia.

Those without prior exposure to venetoclax experienced the most benefit.

Diabetic patients are more susceptible to severe COVID-19 outcomes.

Dr. Kausik Ray presents new data on inclisiran and bempedoic acid as cholesterol lowering medications.

This combination therapy may have a few advantages over standard corticosteroid regimens.

The indication is based on 48-week results showing significant benefit in reduced HAE attacks among pediatric and adult patients.

Patients with normal eGFR increased from 60% at baseline to 80% at 3 years following procedure.

Despite the difficult circumstances, experts believe colorectal cancer rates will not decrease in the coming years due to delays in screenings.

The top-line results from the ABX464 study conducted in 15 European countries, as well as the US and Canada, are expected during the second quarter of 2021.

Adherence was also reported to be high, yet variable, with use of wireless pillboxes and video-based observed therapy.

The TMIOA Medical Director highlights the best sessions, new topics, and growing discussion around the 18th annual congress.

The drug is indicated in capsule form for adults and in a liquid formulation for children.

2020 was the year when regulators, clinicians, and patients had no choice but to embrace the concept of wearable monitoring devices. But it’s been a long time coming for the technology class.

Pediatric patients who initiated insulin pump therapy within 6 months of diagnosis demonstrated better cardiovascular risk profiles than those who delayed treatment.

Repeated Transcranial Magnetic Stimulation shows more efficacy treating bipolar disorder than schizophrenia.

If approved, the vaccine may become available to the US public as early as December 21st.

In a poster presented at ACG, investigators find a new patch test could help patients who are not responding to PPI therapy.

New data shows a large shift from mortality due bacterial infection to other sickle cell disease causes, treatment complications, or non-related comorbidities.

The approval represents the first ever therapy for chronic weight management for obesity caused by a trio of genetic deficiencies.

Families of patients with Dravet syndrome and other rare epileptic burdens have lived under amplified fear this year. That is why telemedicine is a more vital tool than ever.

Inflammatory bowel disease patients were surveyed about their remission or flare-up status, as well as their expectations for a flare-up over the next 2 months.

The risk of suicidality and psychological adverse events appears to be particularly high in younger men with alopecia who are given finasteride.

The first case report of COVID-19 reinfection in a patient with beta thalassemia major describes absence of symptoms and two-month interval between positive PCR tests.

Patients with late-onset asthma and allergies had an increased risk of COPD as well as a heightened risk of landing in the “multiple disorders” comorbidity profile.

In today's issue of Rheumatology Network, we introduce The Concoff Method, a new column by Andrew Concoff, M.D., a rheumatologist who serves as executive vice president and chief value medical officer of United Rheumatology. Over the course of the next year, Dr. Concoff will publish columns that address sports medicine, value in rheumatology and managing a medical practice in the era of COVID-19. In this inaugural issue of the column, he covers the interface between sports medicine and rheumatology.

Liquidia Technologies plans on addressing FDA concerns regarding treprostinil.

Patients with hematological disorders like sickle cell disease or β-thalassemia are at high risk for HCV infection as a result of frequent transfusions.

Literature is scarce in identifying and characterizing risk of post-operative diabetes mellitus among patients with pancreatic cystic lesions.